Motavizumab (MEDI-524) is a monoclonal antibody targeted against the human Respiratory Syncytial Virus (RSV). This antibody is specifically designed for research into the prevention and treatment of RSV infections in high-risk infant populations. Motavizumab binds to the F protein of RSV, neutralizing the virus and potentially preventing the viral fusion with host cell membranes, a key step in the viral infection process. This makes it an invaluable tool for studies aimed at understanding and mitigating RSV pathogenesis in susceptible infant groups.
Motavizumab (MEDI-524) is a monoclonal antibody targeted against the human Respiratory Syncytial Virus (RSV). This antibody is specifically designed for research into the prevention and treatment of RSV infections in high-risk infant populations. Motavizumab binds to the F protein of RSV, neutralizing the virus and potentially preventing the viral fusion with host cell membranes, a key step in the viral infection process. This makes it an invaluable tool for studies aimed at understanding and mitigating RSV pathogenesis in susceptible infant groups.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
